Clinical trials are essential for evaluating potential new treatments, advancing the standard of care, and improving patient outcomes, yet only about five percent of Americans participate in them.

Join The Hill, virtually on May 20th, as we discuss measures Congress can take to make clinical trials more accessible to patients. Our program will address the economics behind clinical trials, biggest barriers to participation and how it affects the future of drug development.

SPEAKERS:

Rep. Chrissy Houlahan (D-Pa.), Co-Sponsor, Harley Jacobsen Clinical Trial Participation Act
Dr Larry Bucshon, Former Congressman & Senior Policy Advisor, Holland & Knight
Lisa Lacasse, President, American Cancer Society Cancer Action Network
Gary Puckrein, President & CEO, National Minority Quality Forum (NMQF)

MODERATOR:

Event Details
Date: Tuesday, March 20
Program begins: 2:00 p.m ET
Program concludes: 2:45 p.m ET

Location: Virtual

Recommend The Hill's newsletters to a friend: TheHill.com/signup.

400 N Capitol Street NW Suite 650, Washington, DC 20001

To ensure you receive these emails in the future, please add
thehill@email.thehill.com to your address book, contacts or safe senders list.

If you believe this has been sent to you in error, please safely unsubscribe.